Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies. - Yeh WZ; Van Der Walt A; Skibina OG; Kalincik T; Alroughani R; Kermode AG; Fabis-Pedrini MJ; Carroll WM; Lechner-Scott J; Boz C; Ozakbas S; Buzzard K; et al. (Neurology(R) neuroimmunology & neuroinflammation, 2024)